Legend Biotech (LEGN) Operating Income (2019 - 2025)
Historic Operating Income for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$43.5 million.
- Legend Biotech's Operating Income rose 3823.98% to -$43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.2 billion, marking a year-over-year increase of 19893.44%. This contributed to the annual value of -$146.9 billion for FY2024, which is 5643.92% down from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Operating Income is -$43.5 million, which was up 3823.98% from $337.9 million recorded in Q2 2025.
- Legend Biotech's Operating Income's 5-year high stood at $137.6 billion during Q4 2024, with a 5-year trough of -$13.4 billion in Q1 2021.
- Moreover, its 5-year median value for Operating Income was $125.5 million (2023), whereas its average is $9.1 billion.
- As far as peak fluctuations go, Legend Biotech's Operating Income tumbled by 2385028.91% in 2021, and later soared by 4181157.14% in 2023.
- Over the past 5 years, Legend Biotech's Operating Income (Quarter) stood at $89.8 million in 2021, then grew by 21.62% to $109.2 million in 2022, then surged by 41811.57% to $45.8 billion in 2023, then skyrocketed by 200.51% to $137.6 billion in 2024, then plummeted by 100.03% to -$43.5 million in 2025.
- Its Operating Income was -$43.5 million in Q3 2025, compared to $337.9 million in Q2 2025 and $287.5 million in Q1 2025.